Dexmedetomidine alleviates pain in MPTP-treated mice by activating the AMPK/mTOR/NF-κB pathways in astrocytes

[1]  D. Song,et al.  Dexmedetomidine Can Enhance PINK1/Parkin-Mediated Mitophagy in MPTP-Induced PD Mice Model by Activating AMPK , 2022, Oxidative medicine and cellular longevity.

[2]  D. Song,et al.  Dexmedetomidine protects SH‐SY5Y cells against MPP+‐induced declining of mitochondrial membrane potential and cell cycle deficits , 2021, The European journal of neuroscience.

[3]  M. Borghesan,et al.  Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression. , 2021, Molecular cell.

[4]  M. Goulding,et al.  Mechanical Allodynia Circuitry in the Dorsal Horn Is Defined by the Nature of the Injury , 2020, Neuron.

[5]  Daying Zhang,et al.  Silencing of lncRNA Gm14461 alleviates pain in trigeminal neuralgia through inhibiting astrocyte activation , 2020, IUBMB life.

[6]  F. Quintana,et al.  Astrocyte Crosstalk in CNS Inflammation , 2020, Neuron.

[7]  Shining Xun,et al.  Dexmedetomidine alleviates neuropathic pain by regulating JAK/STAT pathway in rats , 2020, Journal of cellular biochemistry.

[8]  T. Walsh,et al.  The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies , 2019, Critical Care.

[9]  H. Haghdoost-Yazdi,et al.  Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of KATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms. , 2019, Toxicology and applied pharmacology.

[10]  R. Barker,et al.  Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system. , 2019, Brain : a journal of neurology.

[11]  L. Zheng,et al.  The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway , 2019, Acta Pharmacologica Sinica.

[12]  Jie Chen,et al.  Mesenchymal stem cells-derived IL-6 activates AMPK/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic-ischemic brain damage , 2019, Experimental Neurology.

[13]  Ying-ying Zhou,et al.  Dexmedetomidine Mitigates Microglia-Mediated Neuroinflammation through Upregulation of Programmed Cell Death Protein 1 in a Rat Spinal Cord Injury Model. , 2018, Journal of neurotrauma.

[14]  Chinfei Chen,et al.  Touch and Tactile Neuropathic Pain Sensitivity Are Set by Corticospinal Projections , 2018, Nature.

[15]  N. Williams,et al.  A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease , 2018, Parkinsonism & related disorders.

[16]  P. Blanchet,et al.  Chronic pain and pain processing in Parkinson's disease , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  Na Liu,et al.  The role of autophagy in pro‐inflammatory responses of microglia activation via mitochondrial reactive oxygen species in vitro , 2017, Journal of neurochemistry.

[18]  M. Kondo,et al.  Building a 5-HT3A Receptor Expression Map in the Mouse Brain , 2017, Scientific Reports.

[19]  N. Morioka,et al.  Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice , 2015, Brain, Behavior, and Immunity.

[20]  J. Sandkühler.  Translating synaptic plasticity into sensation. , 2015, Brain : a journal of neurology.

[21]  Xisheng Yan,et al.  Adenosine Monophosphate–activated Protein Kinase Regulates Interleukin-1&bgr; Expression and Glial Glutamate Transporter Function in Rodents with Neuropathic Pain , 2015, Anesthesiology.

[22]  M. Zhuo,et al.  Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) , 2015, Molecular pain.

[23]  L. Ghasemi‐Mobarakeh,et al.  In vivo integration of poly(ε-caprolactone)/gelatin nanofibrous nerve guide seeded with teeth derived stem cells for peripheral nerve regeneration. , 2014, Journal of biomedical materials research. Part A.

[24]  P. Mantyh.  Bone cancer pain: from mechanism to therapy , 2014, Current opinion in supportive and palliative care.

[25]  F. Durif,et al.  Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia , 2014, Brain and behavior.

[26]  S. Pluchino,et al.  Uncovering novel actors in astrocyte–neuron crosstalk in Parkinson's disease: the Wnt/β‐catenin signaling cascade as the common final pathway for neuroprotection and self‐repair , 2013, The European journal of neuroscience.

[27]  H. Braak,et al.  Spinal cord lesions in sporadic Parkinson’s disease , 2012, Acta Neuropathologica.

[28]  F. Biagioni,et al.  Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice , 2012, Journal of Chemical Neuroanatomy.

[29]  W. Oertel,et al.  Pain sensitivity and clinical progression in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[30]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[31]  R. Niranjan,et al.  The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6 , 2010, Free radical research.

[32]  L. Stone,et al.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. , 2009, Pharmacology & therapeutics.

[33]  John Mitrofanis,et al.  Patterns of FOS Expression in the Spinal Cord and Periaqueductal Grey Matter of 6OHDA-Lesioned Rats , 2008, The International journal of neuroscience.

[34]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[35]  A. Stalder,et al.  Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model , 2000, Neuroreport.

[36]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[37]  S. Hunskaar,et al.  Acute and long term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in tests of nociception in mice. , 1992, Pharmacology & toxicology.